Scientists develop breath test to ID people and check health
But a team of scientists have found every breath you take to be like a fingerprint that discloses who you are with 97% accuracy and can be assessed for "insights" into physical and even mental health.
"You would think that breathing has been measured and analyzed in every way," said Noam Sobel, one of a team of researchers based at the Weizmann Institute of Science near Tel Aviv who said they "stumbled upon a completely new way to look at respiration" they describe as "a brain readout."
The researchers tracked breathing in 100 "healthy young adults" over 24 hours using a "lightweight wearable device" they made and found that the "high-level accuracy" of the tests "remained consistent across multiple retests conducted over a two-year period."
Most breathing tests last less than half an hour, meaning such "brief snapshots" cannot assess "subtle patterns," according to the team, which had its findings published in the Cell Press journal Current Biology.
"I thought it would be really hard to identify someone because everyone is doing different things, like running, studying, or resting," said researcher Timna Soroka. But according to the team, the breathing test rivals "the precision of some voice recognition technologies."
"It turns out their breathing patterns were remarkably distinct," Soroka said, following the longer-than-usual test, which not only could identify people but provide signals related to health.
The Israel-based team said that the tests showed breathing to be "correlated with a person's body mass index, sleep-wake cycle, levels of depression and anxiety, and even behavioural traits."
"For example, participants who scored relatively higher on anxiety questionnaires had shorter inhales and more variability in the pauses between breaths during sleep," the researchers reported.
The team's laboratory's prior investigations of olfaction in animals got them thinking that since mammals' brains process odour information during inhalation, there could be some value in testing whether there people have a unique breathing pattern in the same way each brain is unique.
The findings follow the development over the past decade of gadgets that can identify people by how they walk, with so-called gait recognition technology used by police in China in street cameras since at least 2018.
It all means that with every breath you take and every move you make, they might some day be watching - and identifying - you.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
6 minutes ago
- Forbes
Peer Education: One Of The Most Underrated Growth Engines In Medtech
Tlalit Bussi Tel Tzure is the Vice President of Business Development and Global Marketing for the Medical Device Company, IceCure Medical. In medtech, where adoption of new technologies can be cautious and slow, one powerful driver that often goes overlooked is peer education. We've all experienced the power of a referral—when someone you trust recommends a book, a treatment or a restaurant, you're far more likely to give it a try. It's not about the pitch. It's about trust. In medicine, that same dynamic plays out every day. When physicians learn directly from their peers—not sales reps or marketing teams—it carries real weight. A simple, authentic statement like 'I've used this technology, and it really helped my patient' can open doors that no polished demo ever could. In this article, I will share my experience on why peer education works so well in medtech—and how, when done right, it can become a strategic engine for growth and lasting adoption. When Trust And Confidence Start With Peer Experience In healthcare, it makes perfect sense that doctors are cautious with new treatment options. These are decisions that deeply impact the health of patients, and no one takes that lightly. That's why it's so powerful when a physician can speak to someone who's already using the technology and come out the other side more confident. I remember clearly the first time I witnessed this in action: the power of one physician describing their experience with my company's cryoablation system to a colleague who was still on the fence. There was no fancy presentation. No pressure. Just a real, honest conversation rooted in clinical experience. That kind of exchange doesn't just build trust; it fosters real confidence. This is why peer education is more than just a helpful tool, but rather a growth engine that can open doors and create the kind of clinician-led adoption that drives long-term success. Why Peer Learning Works—Business Value, Not Just Clinical Comfort Doctors are not interested in being 'sold to' by companies. They want stories from the field from someone who has used the same tool in real-life situations and can speak authentically about patient outcomes. Peer education works because it bridges the gap between theory and practice and opens a dialogue. Sharing a lived experience delivers clinical credibility and emotional reassurance. It shortens the path to adoption and lowers the perceived risk of using a new technique. This is why I see peer-to-peer education as an extension of a company's go-to-market strategy. It's how companies can accelerate confidence, build adoption and, ultimately, support better care. Peer Learning Models That Work: Intimate, Strategic And High-Touch In medtech, the most effective peer education models are those that align closely with how physicians prefer to learn: through authentic, practical interactions with their peers. Rather than relying on sales-driven presentations, smaller hands-on sessions—often led by experienced users or key opinion leaders (KOLs)—create space for authentic clinical discussions. I have found these intimate, peer-led formats consistently foster deeper engagement and greater confidence in adopting new technologies and can do more to shift clinical perspective than months of traditional follow-up. Tailoring Peer Education To Different Prospect Types Not every physician learns the same way. Senior clinicians and KOLs often benefit most from direct, strategic dialogue with respected global peers. I've seen this in action: A leading breast surgeon from the United States and a radiologist from South Africa engaged with a highly regarded breast surgeon who is one of the pioneers of breast cancer cryoablation. The learning went far beyond technical instruction—it became a strategic conversation between peers shaping the future of care. But other surgeons and breast radiologists who are focused on broadening their treatment offerings may prefer accessible formats like hands-on workshops at events such as those held by the Society of Breast Imaging or the American Society of Breast Surgeons. Sessions like these can offer practical exposure and structured learning through a recognized association of experts in their medical specialty. Building The Right KOL Relationships—Years In The Making Building successful KOL relationships relies on trust built over the years. KOLs aren't just spokespeople; they are strategic collaborators, early product co-creators and long-term champions. The most impactful KOLs often: • Help shape device usage and treatment protocols. • Participate in investigator-led studies, case reports and webinars. • Provide critical feedback that informs product direction. Throughout my years in the medical device field, I've seen firsthand how building the right relationship with a KOL who is truly passionate about delivering the best patient care can turn them into an exceptional product advocate. Involving physicians in shaping your technology and empowering them to help educate the next generation of doctors is not only rewarding—it can become a powerful driver of your business model. As another example, an interventional radiologist from CHU de Nimes in France hosted several fellow radiologists from throughout Europe who were looking to expand their knowledge in treating a broader range of tumor types. Through case discussions and observation, he helped his fellow professionals to explore how to apply new tools more widely in their own clinical settings. Why Trust Is The Real Growth Strategy Peer education isn't just a marketing gimmick. It is a key business strategy that plays a central role in adoption, especially for high-consideration products that require trust, not just awareness. When it's done well, peer education delivers more than conversions. It leads to stronger relationships, richer feedback loops and long-term growth. It transforms passive users into active champions. When people believe in your product and your team, that belief spreads faster than any campaign ever could. Forbes Business Development Council is an invitation-only community for sales and biz dev executives. Do I qualify?


Business Wire
34 minutes ago
- Business Wire
Tenovi Ranks No. 55 on the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
PORTSMOUTH, N.H.--(BUSINESS WIRE)-- Tenovi, a leading provider of full-stack remote monitoring solutions, has earned the No. 55 spot on Inc. Magazine's 2025 Inc. 5000 list, ranking the fastest-growing private companies in the U.S. The company also achieved No. 1 in New Hampshire, No. 2 in the Boston metro area, and No. 11 nationally in healthcare, reflecting exceptional growth and impact in the digital health sector. Tenovi, NH-based remote monitoring solutions leader, ranked No. 55 on Inc. 5000; No. 11 healthcare; No. 1 NH; No. 2 Boston after 4,890% growth. From 2021 to 2024, Tenovi's revenue surged 4,890%, powered by its rapidly expanding national footprint. As of August 2025, the company has shipped 268,000 devices and served a quarter million patients. 'Too many patients wait months between visits and those delays create dangerous gaps in care,' said Nizan Friedman, Ph.D., Co-Founder and CEO of Tenovi. 'Our mission is to close those gaps by simplifying remote care with connected devices that put patients first. By combining clinical integrity, seamless integration, and secure, real-time data, we give care teams the tools to deliver proactive, measurable outcomes. This is just the beginning.' 'Our primary goal is to simplify remote care by providing tools that 'just work' for the people that matter most: patients and their clinical care teams,' said Daniel Zondervan, Ph.D., Co-Founder and CTO of Tenovi. 'Landing at number 55 on the Inc. 5000 list reinforces our belief in that approach. We're on the right path, and we're just getting started.' Tenovi's growth reflects rising demand for device-agnostic, EHR-integrated remote monitoring platforms that work across every care environment. Today, Tenovi supports 180+ partners, 40+ FDA-cleared devices, and care teams in all 50 states, spanning health systems, community health centers, RPM companies, health plans, pharmacies, and digital health innovators. At the core of Tenovi's infrastructure-first model is the Tenovi Gateway, which removes connectivity barriers by enabling plug-and-play remote monitoring: no apps, no Wi-Fi, and no syncing required. Clinicians can scale RPM and RTM programs across any patient population with real-time access to actionable data. This solution-centered approach is supported by world-class fulfillment, patient engagement, and clinical support, all central to Tenovi's mission of improving lives by simplifying remote care. For the full list, company profiles, and a searchable database by industry and location, visit: Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons About Tenovi Tenovi is a data aggregation and automation Healthcare IoT platform that connects remote medical device data with clinical care teams. It provides over 40 remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) device point solutions that integrate with its proprietary Cellular Gateway, automating the transfer of patient vitals. Tenovi's API-driven fulfillment and automation services enable seamless deployment of remote patient and therapeutic monitoring programs. For more information, visit About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit


Business Upturn
5 hours ago
- Business Upturn
Lupin partners with Sandoz to commercialize Ranibizumab biosimilar in multiple global markets
By Aditya Bhagchandani Published on August 12, 2025, 11:08 IST Lupin Limited announced on August 12 that it has entered into a licensing and commercialization agreement with Switzerland-based Sandoz Group AG for its biosimilar Ranibizumab. The deal covers multiple regions, including the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia. Under the agreement, Lupin will handle manufacturing and regulatory submissions, while Sandoz will oversee commercialization. Sandoz will hold exclusive marketing rights in most designated markets, except for France, Australia, Vietnam, and Malaysia, where rights will be semi-exclusive. In a separate arrangement, Sandoz will acquire sole commercialization rights for Canada. Ranibizumab is a monoclonal antibody fragment that binds to and inhibits VEGF-A, used in treating conditions such as Neovascular (Wet) Age-Related Macular Degeneration, Diabetic Macular Edema, Proliferative Diabetic Retinopathy, and other retinal diseases. Thierry Volle, President EMEA and Emerging Markets at Lupin, said the partnership aligns with both companies' vision to expand global access to advanced biologic therapies and improve outcomes for underserved patients. Lupin, a global pharmaceutical leader headquartered in Mumbai, has a presence in over 100 markets, with 15 manufacturing sites and seven research centers worldwide. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.